ICU Medical, Inc. ICUI
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.18B | 2.16B | 2.16B | 2.23B | 2.32B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.18B | 2.16B | 2.16B | 2.23B | 2.32B |
| Cost of Revenue | 1.33B | 1.33B | 1.34B | 1.41B | 1.47B |
| Gross Profit | 849.72M | 826.25M | 818.16M | 822.04M | 846.31M |
| SG&A Expenses | 616.71M | 615.07M | 622.54M | 625.21M | 628.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.04B | 2.03B | 2.05B | 2.12B | 2.19B |
| Operating Income | 146.19M | 124.85M | 110.13M | 109.33M | 129.30M |
| Income Before Tax | 37.23M | -866.00K | 9.49M | 3.17M | 29.77M |
| Income Tax Expenses | -23.10M | -30.96M | -36.85M | 2.44M | 37.14M |
| Earnings from Continuing Operations | 60.33 | 30.09 | 46.34 | 0.73 | -7.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 60.33M | 30.09M | 46.34M | 732.00K | -7.36M |
| EBIT | 146.19M | 124.85M | 110.13M | 109.33M | 129.30M |
| EBITDA | 346.25M | 326.12M | 311.45M | 310.08M | 332.21M |
| EPS Basic | 2.42 | 1.21 | 1.88 | 0.03 | -0.31 |
| Normalized Basic EPS | 1.86 | 1.35 | 0.90 | 0.74 | 1.09 |
| EPS Diluted | 2.39 | 1.18 | 1.85 | 0.02 | -0.32 |
| Normalized Diluted EPS | 1.85 | 1.35 | 0.90 | 0.74 | 1.08 |
| Average Basic Shares Outstanding | 99.46M | 99.14M | 98.78M | 98.56M | 98.36M |
| Average Diluted Shares Outstanding | 100.06M | 99.60M | 99.26M | 98.62M | 98.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |